TI-001 (Intranasal Oxytocin) for Treatment of High Frequency Episodic Migraine and Chronic Migraine
Clinical trial NCT01839149 · COMPLETED
Trial details
- NCT number
- NCT01839149
- Sponsor
- Trigemina, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2015-10-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.